We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$52.5B
AUM Growth
-$68.7M
Cap. Flow
-$1.64B
Cap. Flow %
-3.13%
Top 10 Hldgs %
8.03%
Holding
3,774
New
423
Increased
1,687
Reduced
1,158
Closed
474

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$363M
2
NKE icon
Nike
NKE
+$289M
3
HD icon
Home Depot
HD
+$271M
4
MA icon
Mastercard
MA
+$180M
5
AMZN icon
Amazon
AMZN
+$158M

Sector Composition

Rank Sector Weight
1 Technology 13.84%
2 Healthcare 12.18%
3 Financials 11.43%
4 Industrials 9.05%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TORM
3201
DELISTED
TOR Minerals International Inc
TORM
$69K ﹤0.01%
15,000
+600
+4% +$2.64K
VII
3202
DELISTED
Vicon Industries, Inc.
VII
$68K ﹤0.01%
133,700
+3,100
+2% +$2.3K
INVN
3203
DELISTED
Invensense Inc
INVN
$68K ﹤0.01%
11,100
-108,600
-91% -$750K
TOF
3204
DELISTED
TOFUTTI BRANDS INC
TOF
$68K ﹤0.01%
32,000
+100
+0.3% +$278
QBAK
3205
DELISTED
Qualstar Corp
QBAK
$68K ﹤0.01%
19,702
+552
+3% +$1.63K
IMNN icon
3206
Imunon
IMNN
$6.43M
$66K ﹤0.01%
19
+9
+90% +$35.4K
PLX icon
3207
Protalix BioTherapeutics
PLX
$193M
$66K ﹤0.01%
10,290
+4,800
+87% +$38.4K
TRX icon
3208
TRX Gold Corp
TRX
$263M
$66K ﹤0.01%
93,900
+11,800
+14% +$4.98K
CMLS
3209
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$65K ﹤0.01%
+26,045
New +$75.1K
OCGN icon
3210
Ocugen
OCGN
$427M
$64K ﹤0.01%
620
+272
+78% +$33.1K
WINT
3211
DELISTED
Windtree Therapeutics Inc
WINT
$64K ﹤0.01%
32,991
+7,508
+29% +$18.1K
CVU icon
3212
CPI Aerostructures
CVU
$63.1M
$63K ﹤0.01%
10,300
-21,800
-68% -$142K
PRQR icon
3213
ProQR Therapeutics
PRQR
$244M
$63K ﹤0.01%
+13,000
New +$66.9K
KGJI
3214
DELISTED
Kingold Jewelry Inc.
KGJI
$63K ﹤0.01%
5,817
+1,867
+47% +$16.9K
CASI
3215
DELISTED
CASI Pharmaceuticals
CASI
$62K ﹤0.01%
5,260
+890
+20% +$11.2K
NSPR icon
3216
InspireMD
NSPR
$32.3M
0
ARRY
3217
DELISTED
Array Biopharma Inc
ARRY
$62K ﹤0.01%
17,452
-2,137,200
-99% -$6.96M
CRIS icon
3218
Curis
CRIS
$9.14M
$61K ﹤0.01%
20
+1
+5% +$3.57K
PRPO icon
3219
Precipio
PRPO
$41M
$60K ﹤0.01%
12
+5
+71% +$27K
NBSE
3220
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$60K ﹤0.01%
+55
New +$69.1K
SAUC
3221
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$60K ﹤0.01%
39,300
+3,300
+9% +$5.37K
TLOG
3222
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$60K ﹤0.01%
195,100
-5,400
-3% -$1.5K
TLPH icon
3223
Talphera
TLPH
$65.4M
$57K ﹤0.01%
+1,055
New +$69.1K
KOSS icon
3224
Koss Corp
KOSS
$34.6M
$56K ﹤0.01%
27,700
+2,000
+8% +$4.18K
NSYS icon
3225
Nortech Systems
NSYS
$42M
$55K ﹤0.01%
14,800
+100
+0.7% +$376

Similar funds

Renaissance Technologies's Q2 2016 Portfolio in Review

As of Q2 2016, Renaissance Technologies held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Renaissance Technologies withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Renaissance Technologies opened a new position in Nike worth $280M.

  • Renaissance Technologies's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
  • Renaissance Technologies added most to CVS Health in Q2 2016, an estimated $363M increase.
  • Renaissance Technologies's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
  • Renaissance Technologies fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
  • Renaissance Technologies's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
  • Renaissance Technologies opened 423 new positions and closed 474 in Q2 2016.
  • Renaissance Technologies's portfolio value fell 0.13% quarter-over-quarter to $52.5B.

Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.